HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
RLAY
Relay Therapeutics Inc
Healthcare Biotechnology · Massachusetts, USA · Reports in usd
Market Cap: $2.62B
Market Cap
$2.62B
Enterprise Val
$2.10B
P/E Ratio
-9.48
P/B Ratio
4.62
Trailing PEG (1Y)
0.36
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$567.1M
Gross Margin100.00%
Profit Margin100.00%
Return on Equity-43.17%
Return on Assets-39.22%
Current Ratio22.61
Debt/Equity0.06
LT Debt/Equity0.05
Revenue Per Share0.04

Income Statement

Dec 31, 2025
Revenue$7.0M
Cost of Revenue$0.00
Gross Profit$7.0M
R&D$55.4M
SG&A$12.2M
Operating Expenses$67.6M
Operating Income-$60.6M
Interest Expense$0.00
Tax Expense$0.00
Net Income-$54.9M
EPS (Basic)$-0.31
EPS (Diluted)$-0.31
EBIT-$54.9M
EBITDA-$54.3M
Consolidated Income-$54.9M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$85.4M
Accounts Receivable$0.00
Inventory$0.00
Current Assets$578.3M
LT Investments$0.00
Property, Plant & Equipment$41.7M
Intangibles$0.00
Non-Current Assets$43.1M
Total Assets$621.3M
Accounts Payable$7.7M
Current Debt$3.8M
Current Liabilities$25.6M
LT Debt$28.7M
Non-Current Liabilities$28.7M
Total Liabilities$54.3M
Total Debt$32.5M
Retained Earnings-$2.01B
Shareholder Equity$567.1M
Shares Outstanding173,322,385

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$44.9M
Investing Cash Flow$35.5M
Financing Cash Flow$934.0K
CapEx-$1.0K
Free Cash Flow-$44.9M
Depreciation & Amort.$599.0K
Stock-Based Comp$13.1M
Acquisitions / Disposals$0.00
Investment Activity$35.5M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$934.0K
Dividends Paid$0.00
Net Change in Cash-$8.5M
Data cached · Meta live · Daily live · Statements live · TTL 24h